Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 33

Trial Status

Completed2
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03719534Phase 3Completed
Haplo HCT vs Haplo-cord HCT for Patients With AML
Acute Myeloid LeukemiaCord Blood UnitHaplo-identical Donor+1 more
PrincipalinvestigatorStart date: 2017-06-01
NCT03919240Phase 1/2Active Not Recruiting
CAR-T Cell Therapy Targeting to CD19 for R/R ALL
Acute Lymphoblastic Leukemia With Failed Remission
PrincipalinvestigatorStart date: 2015-12-01
NCT02059720Phase 3Unknown
Haplo-SCT vs ASCT With or Without Decitabine in AML CR1
Acute Myeloid Leukemia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03719534Phase 3PrincipalInvestigator

Haplo HCT vs Haplo-cord HCT for Patients With AML

Acute Myeloid LeukemiaCord Blood UnitHaplo-identical Donor+1 more
Completed
NCT03919240Phase 1/2PrincipalInvestigator

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Acute Lymphoblastic Leukemia With Failed Remission
Active Not Recruiting
NCT02323022Phase 3PrincipalInvestigator

Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia
Completed
NCT02059720Phase 3PrincipalInvestigator

Haplo-SCT vs ASCT With or Without Decitabine in AML CR1

Acute Myeloid Leukemia
Unknown

All 4 trials loaded